Healthtech Startups
17,200 companies tagged Healthtech, with their investors and founders.
0 investors
PureVita Labs conducts analytic chemistry and clinical research on cannabis, studying its physiologic, psychologic, and therapeutic properties and the role of the endocannabinoid system in various disease states. The company was founded by two medical doctors and a chemist to build evidence about cannabis for medical and patient use.
0 investors
0 investors
Purinomia is a clinical-stage biotechnology company developing therapeutics for cancer and inflammatory diseases. Its pipeline includes the clinical-stage program PUR001 and three pre-clinical programs (PUR002, PUR003, PUR004).
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Pylum Bio is a biotechnology company developing therapeutics, drawing on microbiology, immunology, and molecular genetics research. Its leadership includes founders and directors with backgrounds in pharmaceutical R&D and life sciences.
0 investors
Pymedix develops medical AI software for radiation oncology, including Autofuse, a 3D deformable image registration tool, and automated machine perception technologies for radiotherapy. It serves the radiation oncology field with tools aimed at personalized medicine and data-driven care.
0 investors
0 investors
0 investors
Q'Apel Medical designs purpose-built devices for neurovascular and stroke care, developing tools focused on catheter access and navigation through complex vascular pathways. It develops these solutions in collaboration with neurovascular clinicians to address unmet clinical needs during stroke interventions.
0 investors
Qentoros develops peptide biologic therapeutics for veterinary medicine through its Q-Biologics platform, with the first product BIO-PLY™ in FDA development for infectious, inflammatory, and degenerative diseases.
0 investors
0 investors
QHSLab, Inc. develops a cloud-based digital medicine platform for independent primary care physicians to deliver virtual care, personalized medicine, and chronic disease management through reimbursable software tools. The company targets solo and independent practitioners seeking to increase revenue and improve clinical outcomes in value-based healthcare.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors